Cargando…
ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION
BACKGROUND: Based on EF-14 clinical trial, NovoTTF therapy prolong overall survival in the patients with GBM. However, NovoTTF treatment does not become standard therapy because treatment procedures are cumbersome and potentially impose psychological burden on patients who suffer from dismal disease...
Autores principales: | Yamaguchi, Shigeru, Motegi, Hiroaki, Ishi, Yukitomo, Okamoto, Michinari, Terasaka, Shunsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213267/ http://dx.doi.org/10.1093/noajnl/vdz039.067 |
Ejemplares similares
-
ACT-5 Prognosis of IDH-mut lower-grade gliomas in Hokkaido University Hospital
por: Yamaguchi, Shigeru, et al.
Publicado: (2021) -
ML-04 The influence of surgical intervention for high-dose Methotrexate chemotherapy in the patients with primary central nervous system lymphoma
por: Okamoto, Michinari, et al.
Publicado: (2020) -
Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis
por: YAMAGUCHI, Shigeru, et al.
Publicado: (2021) -
Retrosigmoid Intradural Suprameatal Approach for Petroclival Meningioma
por: Ishi, Yukitomo, et al.
Publicado: (2019) -
Detection of the Moment of Nerve Decompression Using Continuous Monitoring of Evoked Facial Nerve Electromyograms in a Patient with Facial Nerve Schwannoma: Case Report
por: NAKAZAKI, Asuka, et al.
Publicado: (2022)